IDegAsp produces a dose-proportional glucose-lowering effect in subjects with type 1 diabetes

被引：0
|
作者：
Nosek, L. [1 ]
Heise, T. [1 ]
Klein, O. [1 ]
Coester, H. -V. [1 ]
Roepstorff, C. [2 ]
Svendsen, A. [2 ]
Haahr, H. [2 ]
机构：
[1] Profil Inst Stoffwechselforsch, Neuss, Germany
[2] Novo Nordisk AS, Soborg, Denmark
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1041
引用
收藏
页码：S418 / S419
页数：2
相关论文
共 50 条
  • [31] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
  • [32] Effectiveness of glucose-lowering therapy in type 2 diabetes in primary care
    Jacobs, Esther
    Kostev, Karel
    Rathmann, Wolfgang
    [J]. DIABETOLOGE, 2019, 15 (02): : 89 - 95
  • [33] Role of bile acids on glucose-lowering by metformin in type 2 diabetes
    Sansome, D. J.
    Veedfald, S.
    Xie, C.
    Bound, M.
    Grivell, J.
    Jones, K. L.
    Horowitz, M.
    Rayner, C. K.
    Wu, T.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S14 - S15
  • [34] COST OF TYPE 2 DIABETES ACCORDING TO GLUCOSE-LOWERING MEDICATIONS IN FRANCE
    Charbonnel, B.
    Dallongeville, J.
    Simon, D.
    Bureau, I
    Leproust, S.
    Levy-Bachelot, I
    Gourmelen, J.
    Detournay, B.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A604 - A604
  • [35] Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
    Xie, Wenting
    Su, Fugui
    Wang, Guizhong
    Peng, Zichong
    Xu, Yaomin
    Zhang, Yi
    Xu, Ningning
    Hou, Kaijian
    Hu, Zhuping
    Chen, Yan
    Chen, Rongping
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Association study of six type 2 diabetes genes and glucose-lowering effect of sulfonylurea drugs
    Schroner, Z.
    Javorsky, M.
    Klimcakova, L.
    Dobrikova, M.
    Habalova, V.
    Babjakova, E.
    Zidzik, J.
    Fabianova, M.
    Slaba, E.
    Kozarova, M.
    Tkacova, R.
    Salagovic, J.
    Tkac, I.
    [J]. DIABETOLOGIA, 2011, 54 : S123 - S123
  • [37] The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes
    Jangsiripornpakorn, Jintanan
    Srisuk, Sasima
    Chailurkit, Laor
    Nimitphong, Hataikarn
    Saetung, Sunee
    Ongphiphadhanakul, Boonsong
    [J]. BMC RESEARCH NOTES, 2022, 15 (01)
  • [38] The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes
    Jintanan Jangsiripornpakorn
    Sasima Srisuk
    Laor Chailurkit
    Hataikarn Nimitphong
    Sunee Saetung
    Boonsong Ongphiphadhanakul
    [J]. BMC Research Notes, 15
  • [39] Enhanced glucose-lowering effect of dipeptidyl peptidase-4 inhibitor in subjects with type 2 diabetes who have a history of gastrectomy
    Wada, Y.
    Hamamoto, Y.
    Honjo, S.
    Fujimoto, K.
    Tatsuoka, H.
    Matsuoka, A.
    Ikeda, H.
    Fujikawa, J.
    Koshiyama, H.
    [J]. DIABETOLOGIA, 2014, 57 : S359 - S360
  • [40] Intensive glucose-lowering: long-lasting benefits on albuminuria in patients with type 1 diabetes
    Susan J. Allison
    [J]. Nature Reviews Nephrology, 2014, 10 (9) : 481 - 481
12345